PhaseRx, Inc.
PZRXQ · OTC
9/30/2017 | 6/30/2017 | 3/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $1,729 | $2,255 | $2,326 | $2,025 |
| G&A Expenses | $806 | $1,065 | $1,589 | $1,243 |
| SG&A Expenses | $806 | $1,065 | $1,589 | $1,243 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,535 | $3,320 | $3,915 | $3,268 |
| Operating Income | -$2,535 | -$3,320 | -$3,915 | -$3,268 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$215 | -$219 | -$210 | -$209 |
| Pre-Tax Income | -$2,750 | -$3,539 | -$4,125 | -$3,477 |
| Tax Expense | $16 | $22 | $25 | $6 |
| Net Income | -$2,750 | -$3,539 | -$4,125 | -$3,477 |
| % Margin | – | – | – | – |
| EPS | -0.24 | -0.3 | -0.35 | -0.3 |
| % Growth | 20% | 14.3% | -16.7% | – |
| EPS Diluted | -0.24 | -0.3 | -0.35 | -0.3 |
| Weighted Avg Shares Out | 11,690 | 11,690 | 11,690 | 11,690 |
| Weighted Avg Shares Out Dil | 11,690 | 11,690 | 11,690 | 11,690 |
| Supplemental Information | – | – | – | – |
| Interest Income | $16 | $22 | $25 | $27 |
| Interest Expense | $231 | $241 | $235 | $236 |
| Depreciation & Amortization | $20 | $21 | $21 | $21 |
| EBITDA | -$2,499 | -$3,277 | -$3,869 | -$3,220 |
| % Margin | – | – | – | – |